0001493152-23-003227.txt : 20230201
0001493152-23-003227.hdr.sgml : 20230201
20230201060239
ACCESSION NUMBER: 0001493152-23-003227
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230127
FILED AS OF DATE: 20230201
DATE AS OF CHANGE: 20230201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ohri Manu
CENTRAL INDEX KEY: 0001424683
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40023
FILM NUMBER: 23574628
MAIL ADDRESS:
STREET 1: 2355 MAIN STREET
STREET 2: SUITE 120
CITY: IRVINE
STATE: CA
ZIP: 92614
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: SUITE 100
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 8000 MARINA BLVD
STREET 2: SUITE 100
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
ownership.xml
X0306
4
2023-01-27
0
0000109657
GT Biopharma, Inc.
GTBP
0001424683
Ohri Manu
C/O GT BIOPHARMA, INC.
8000 MARINA BLVD., STE. 100
BRISBANE
CA
94005
0
1
0
0
Chief Financial Officer
Option to purchase Common Stock
0.837
2023-01-27
4
A
0
500000
0.00
A
2033-01-26
Common Stock
500000
500000
D
1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.
/s/ Manu Ohri
2023-01-31